HECA yields 1.93% · MRK yields 2.81%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, HECA + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HECA + MRK for your $10,000?
HECA is a multi-asset strategy designed to maximize returns over rolling 12-month periods while limiting drawdowns to no more than 15%. Investments include asset classes such as equities, fixed income, commodities, and currencies. The strategy centers on a proprietary Quad model, a regime-based, quantitative framework that analyzes the rate-of-change in economic growth, inflation, and monetary policy trends. Portfolio allocation is based on these macro signals, identifying asset classes based on the respective market environment. Additionally, it enhances this framework with internal and external research to identify emerging themes and investment opportunities. The fund primarily invests through US-listed ETFs but may also hold individual equity and debt securities. The fund also uses an options overlay to hedge downside risk, adjust exposures, or enhance returns. Note that the portfolio is not subject to any predetermined allocation limits across specific regions.
Full HECA Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.